Articles published by ImmunityBio, Inc.
![](https://mms.businesswire.com/media/20220523005627/en/1463552/5/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20220428005514/en/1408631/5/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20220425005375/en/1408631/5/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20220401005494/en/1408627/5/BusinessWire_-ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20220215005558/en/760385/5/ImmunityBio.jpg)
ImmunityBio Completes Acquisition of Athenex’s Interest in Dunkirk, New York Advanced Biotech Manufacturing Facility
February 15, 2022
From ImmunityBio, Inc.
Via Business Wire
Tickers
IBRX
![](https://mms.businesswire.com/media/20220214005880/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20220131005962/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20220118006235/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20220112005430/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20220104005428/en/760385/5/ImmunityBio.jpg)
ImmunityBio Awarded Seminal Patent on Natural Killer Cells
January 04, 2022
From ImmunityBio, Inc.
Via Business Wire
Tickers
IBRX
![](https://mms.businesswire.com/media/20211220005286/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20211118005433/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20211104005486/en/760385/5/ImmunityBio.jpg)
ImmunityBio to Present at the Jefferies London Healthcare Conference
November 04, 2021
From ImmunityBio, Inc.
Via Business Wire
Tickers
IBRX
![](https://mms.businesswire.com/media/20211019005500/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20211013005442/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20211004005349/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210913005298/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210907005330/en/760385/5/ImmunityBio.jpg)
ImmunityBio Builds Commercial Team with the Appointment of Seasoned Marketing and Reimbursement Executives
September 07, 2021
From ImmunityBio, Inc.
Via Business Wire
Tickers
IBRX
![](https://mms.businesswire.com/media/20210901005358/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210816005236/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210727005426/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210714005348/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210628005267/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210615005489/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210610005332/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210525005370/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210524005167/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210520005394/en/760385/5/ImmunityBio.jpg)
![](https://mms.businesswire.com/media/20210517005316/en/760385/5/ImmunityBio.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.